Brad Marchand Had Surgery He Was Trying to Avoid and the Panthers May Start Without Him

Brad Marchand confirmed in mid-August that he underwent surgery, disclosing it while explaining why he could not take part in Zdeno Chara's charity game in Slovakia. The 38-year-old Panthers forward said he had been trying to fix the problem without an operation and ultimately had the procedure done late. Reporting indicates the issue involves a hip and a sports hernia, and that he could miss the start of the 2026-27 season.

George Richards of Florida Hockey Now has suggested the absence could run two months or more from the date of the procedure. Florida has not put out a formal timeline, and the specifics of what was repaired have not been confirmed by the team.

The part that explains last season

Marchand played through this for a large portion of the 2025-26 season, including the Winter Olympics in February, where he represented Canada. That detail reframes his year. A player grinding through a hip and core issue for months while playing in a compressed Olympic schedule on top of an NHL season is a player whose production was being suppressed by something other than age.

That cuts both ways for a fantasy projection. The optimistic reading is that a healthy Marchand in November is better than the version fantasy managers watched last spring, and that his decline has been partly medical rather than entirely chronological. The pessimistic reading is that a 38-year-old who needed surgery for a hip and a core muscle problem after playing through it for a season is a player whose body is telling him something.

Both readings are defensible. The honest answer is that nobody, including Florida, knows which one is right until he skates.

Fantasy fallout

Marchand's fantasy value was already in the tier where managers draft him for the power play time and the peripherals rather than for raw point production. A surgery that threatens the first month or more of the season pushes him out of that tier in redraft leagues entirely.

The right move in most formats is to let someone else draft him. A 38-year-old forward coming off hip and core surgery with no confirmed timeline is the definition of a pick that costs a roster spot for six weeks and then pays out at a level a waiver-wire add could match. In deep leagues with injured reserve slots, he becomes a late-round stash rather than a middle-round asset.

The beneficiaries are on Florida's top six. The Panthers have Matthew and Brady Tkachuk in the same lineup now, and a Marchand absence concentrates power play and top-line minutes among a group that already has more offensive talent than it has ice time. Any Florida forward who inherits a first power play unit spot in October is a legitimate fantasy add, and those players are being drafted at depth-piece prices because the depth chart assumes Marchand is in the lineup.

The Verdexed model take

Verdexed's hockey projections handle offseason surgeries by modeling a return-date distribution and then applying a production ramp from that date, with the steepness of the ramp scaled to age and to whether the injury affects skating mechanics.

Hip surgery is the worst category on that second dimension. Skating is the foundation of every other part of a forward's game, and a hip repair degrades the specific movement pattern that generates separation and net-front positioning. The model applies a longer and shallower ramp for hip procedures than for upper-body injuries of comparable severity, and it applies an additional age adjustment for players past 35.

The combined output for Marchand is a projection well below his established baseline for the first quarter of the season and a convergence back toward it, but not fully, by midseason. The model does not project him as finished. It projects him as a player whose useful fantasy contribution starts in November and whose ceiling is lower than it was.

For a contending Florida team, that is a manageable outcome. For a fantasy manager who drafts him in August at a price built on a full season, it is not.

Betting angle

Florida's Stanley Cup price is not moving on a Marchand absence, and it should not. This is a team with elite forward depth, and the marginal value of a 38-year-old third-line contributor to a championship probability is close to noise.

Where it matters is in the October game totals and the individual scoring markets. Any Marchand points-total prop posted before the surgery news was priced on a full season, and a player who misses two months cannot reach a number built on 82 games. Those markets adjust, but the adjustment is often slower than the news, particularly for a player whose absence has not been formally announced by his team.

Florida's early-season team totals are the other consideration. The Panthers open the season with a lineup that is missing a regular contributor and reshuffling its combinations, and reshuffled lines are worth a small fade in the first two weeks regardless of talent level.

What's next

The Panthers have reportedly set an internal target for Marchand's debut, and camp will make the picture clearer. The checkpoints are whether he skates with the group at any point during training camp, whether Florida places him on long-term injured reserve to start the season, and how the Panthers structure their opening-night power play units.

An LTIR placement would confirm a minimum absence and give Florida cap relief, which is a strong hint about the organization's real expectation. A player who is merely scratched game to game is a player the team believes is close. Until one of those happens, treat Marchand as a stash rather than a starter and let the discount come to you.